Low-incidence MNS antigens associated with single amino acid changes and their susceptibility to enzyme treatment

M E Reid1, J R Storry

  • 1Immunohematology Laboratory, New York Blood Center, 310 East 67th Street, New York, NY 10021, USA.

Immunohematology
|September 18, 2004
PubMed

Insights

The MNS blood group system antigens on glycophorin A and B exhibit differential sensitivity to proteolytic enzymes. Molecular studies correlate amino acid changes with antigen behavior, aiding in blood group alloantibody identification.

Area of Science:

  • Immunology
  • Biochemistry
  • Genetics

Background:

  • The MNS blood group system is defined by antigens on glycophorin A (GPA) and glycophorin B (GPB).
  • Differential enzymatic cleavage of GPA and GPB antigens has historically aided in blood group alloantibody identification.
  • Recent advances in molecular analysis have revealed amino acid variations linked to low-incidence MNS antigens.

Purpose of the Study:

  • To review the relationship between molecular variations in MNS blood group antigens and their susceptibility to proteolytic enzymes.
  • To connect recent molecular findings with established enzymatic properties of MNS antigens.

Main Methods:

  • Review of existing literature on MNS blood group system molecular genetics.
  • Analysis of studies detailing the effects of proteolytic enzymes (ficin, papain, trypsin, alpha-chymotrypsin) on red blood cells.
  • Correlation of molecular data with enzymatic cleavage patterns.

Main Results:

  • GPA N-terminus antigens are cleaved by ficin, papain, and trypsin but resistant to alpha-chymotrypsin.
  • GPB N-terminus antigens are cleaved by ficin, papain, and alpha-chymotrypsin but resistant to trypsin.
  • Specific amino acid changes are associated with altered enzymatic susceptibility of MNS antigens.

Conclusions:

  • Molecular insights provide a deeper understanding of MNS antigen behavior.
  • Enzymatic profiles of MNS antigens are directly influenced by their underlying molecular structure.
  • This knowledge enhances the characterization of blood group alloantibodies and MNS antigen variations.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
Mutations01:39

Mutations

Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...